September 2009 Issue of MMM
It's salary survey season again at MM&M and given the economic turbulence that has characterized the past year, we didn't really know what to expect ...
Consolidations and mergers over the last 12 months didn't stop industry paychecks from decreasing for the second year in row. Ben Comer looks at the ...
A challenging economic year has been a mixed blessing for some agencies who find they have a much larger talent pool to choose from. Tanya ...
Pharma marketers have diverse backgrounds. What they have in common is a desire to help patients and dispel negative images of the industry. Here are ...
Back in July, an esteemed panel of 41 expert healthcare executives, spanning the fields of marketing, communications and media, came together to review and score ...
Tom Stossel, MD, the Harvard Medical School professor who took a brave and lonely stand for the value of industry-sponsored CME before a hostile Senate ...
For several years now, people have been writing off the pharmaceutical industry. Blockbuster drugs losing their patents, in concert with decreasing numbers of drug approvals, ...
PhRMA last month secured a wishy-washy public confirmation from the White House that they had an agreement, and promptly launched the first installment of a ...
Aptilon announced the availability of an expanded set of tools that enables biopharmaceutical companies to increase access to valuable, high-prescribing physicians.
Results of a study conducted by ZS Associates designed to benchmark incentive practices in the pharmaceutical and biotech industries revealed an increase of 8% in ...
Featuring news about Manhattan Research, Lilly, Zogenix, Astellas Pharma and Sumavel DosePro
Med Ed Report
The ACCME is a toothless watchdog and should be abolished, said Cleveland Clinic's Dr. Steven Nissen at a Senate Committee on Aging hearing.
Total commercial support of accredited CME dropped 14% to $1 billion in 2008, according to ACCME's annual report—even as the number of physicians participating in ...
The ACCME's August deadline for accredited providers to get right with the new definition of a "commercial interest" has passed.
Featuring news about Lilly, Novo Nordisk and McCann Healthcare Worldwide
Johnson & Johnson used its JNJ BTW blog to introduce an iPhone app for docs, titled BlackBag.
Responding to an increase in diabetes and diabetes care worldwide, Wiley-Blackwell announced that it will launch the Journal of Diabetes Investigation in 2010.
Featuring news about Physicians Interactive, Skyscape, Thomson Reuters, Elsevier's Journal of Food & Ankle Surgery and Lippincott Williams & Wilkins' Nursing2009
Many of the large health networks offer customized advertising capabilities, such as branded "patient rooms" and exclusive video inventory. Is there value in these kinds ...
Everyday Health added the Mayo Clinic's consumer website to its network of health properties, although pharmaceutical advertising on the site will continue to be handled ...
Cardinal Health launched the Pharmacy Health Network in early August, serving up digital prescription and OTC advertising in 3,000 independent retail and franchised pharmacies nationwide.
Featuring news about HealthMedia, StayWell Custom Communications, Compete and the AMA
What do you do if you are an innovative but small "David" of an allergy nasal spray that has to do battle with a "Goliath"—in ...
From the people who brought you the disease awareness documentary comes New Way RA, an online talk show for people with rheumatoid arthritis hosted by ...
FDA warned Abbott about a patient testimonial DVD for its HIV drug Kaletra, starring Earvin "Magic" Johnson. The DVD, I Know What's Important, minimizes the risks, ...
Novo Nordisk has enlisted action film star and ex-wrestler Dwayne "The Rock" Johnson as the latest celebrity face of its Diabetes Aware campaign with the ...
Schering-Plough, Novartis, Johnson & Johnson, Wyeth and others are using Rite Aid's new "video values" site to offer coupons and information about their products.
A survey of patients at Harvard's Dana-Farber Cancer Institute found that 11% said ads for cancer-related drugs had made them less confident in their providers' ...
Featuring news about antidepressant use, Schering-Plough, Claritin Eye and the Genetics and Public Policy Center
Marketing research and e-marketing firm So-net M3 acquired The Smartest Oncologist in America, a daily oncology quiz service, through an acquisition of The SmartestDoc LLC.
IMS Health announced a streamlining of business operations in the wake of second quarter losses.
Publicis will acquire Razorfish, a Microsoft-owned digital and interactive shop, for roughly $530 million, according to joint company statements.
Digitas Health is opening offices in London and Boston to accommodate several years' worth of strong growth, the Publicis network said.
Ogilvy Healthword promoted Gloria Gibbons, president of Ogilvy Healthworld EAME (European-African-Middle Eastern) and Donna Tuths, president of Ogilvy Healthworld North America, to joint worldwide CEOs.
Featuring news about Publicis Strategic Solutions Group, Palio and MS&L
In a move applauded by brand name manufacturers, the Senate Health, Education, Labor and Pensions Committee and its House counterpart voted in July to support ...
The Obama administration's Justice Department says that so-called pay-for-delay arrangements in which an innovator drug company pays a generic drug company to delay entry into ...
Permit me to share some personal information—my eldest son has epilepsy. The good news is that his condition is under control due to the wonders ...
Picture, if you will, this iconic scene from a classic movie. Butch Cassidy and the Sundance Kid are trapped by an oncoming posse. They face ...
Throughout my healthcare PR career, I worked on and headed teams that executed innovative and award-winning campaigns to educate patients and healthcare providers.
Pharma and biotech companies are competing to have enough vaccine on hand for the next swine flu (H1N1) outbreak. They missed the one last winter ...
- Biogen ends Tecfidera DTC campaign, citing prescriptions
- As immuno-oncology therapies evolve, so will the marketing
- GSK Consumer Healthcare to prioritize digital after agency review
- Five things for pharma marketers to know: Thursday, July 21, 2016
- Five things for pharma marketers to know: Tuesday, July 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- 8 ways for pharma to improve the way it uses Twitter
- Five things for pharma marketers to know: Thursday, July 28, 2016
- Infographic: Type 2 diabetes, a country-by-country snapshot
- Moving Forward — Without the Promotion
- Sponsored Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers